Puma Biotechnology, Inc., a biopharmaceutical company, announced the initiation of its ALISertib in CAncer Phase II trial of alisertib monotherapy for the treatment of...
Simulations Plus, Inc., a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, provided additional information on advancing its...
CymaBay Therapeutics, Inc., a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, announced that the U.S. Food and...
With the increasing number of cell and gene therapy products in clinical development, Cencora’s FormularyDecisions launched a new resource designed to provide healthcare payers with...
Walgreens Boots Alliance Chief Executive Officer Tim Wentworth, announced updates to WBA’s Executive Committee as the company advances a health services strategy rooted in...
